Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery
- PMID: 16677756
- PMCID: PMC2734268
- DOI: 10.1016/j.canlet.2006.03.029
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery
Abstract
Preventing peritoneal implantation of ovarian carcinoma cells could prolong patient remission and survival. CA125 is expressed on most ovarian cancer cells and was reported to be a ligand of mesothelin, a peritoneal protein. We developed a cell adhesion assay with CA125-expresser ovarian cancer cells and human mesothelin-transfected cells and we confirmed that CA125 and mesothelin mediate cell attachment. We also showed that this assay supplies a high-throughput screening system for reagents able to block CA125/mesothelin-dependent cell attachment with a sensitive quantitative readout. We finally demonstrated that a mesothelin chimeric protein and anti-CA125 antibodies block CA125/mesothelin-dependent cell attachment.
Figures
References
-
- Rump A, Morikawa Y, Tanaka M, Minami S, Umesaki N, Takeuchi M, et al. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem. 2004;279(10):9190–9198. - PubMed
-
- Yamaguchi N, Yamamura Y, Konishi E, Ueda K, Kojima T, Hattori K, et al. Characterization, molecular cloning and expression of megakaryocyte potentiating factor. Stem Cells. 1996;14(Suppl 1):62–74. - PubMed
-
- Kojima T, Oheda M, Hattori K, Taniguchi Y, Tamura M, Ochi N, et al. Molecular cloning and expression of megakaryocyte potentiating factor cDNA. J Biol Chem. 1995;270(37):21984–21990. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
